Squarepoint’s Lifestance Health LFST Stock Holding History

Squarepoint’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-370,000	Closed	-$2.73M	–	5057
2024 Q4	$2.73M	Buy	370,000 +250,000	+208%	+$1.79M	﹤0.01%	2146
2024 Q3	$840K	Buy	+120,000	New	+$721K	﹤0.01%	2736

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SPIG

Silversmith Partners I GP Boston, Massachusetts $39.2M AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Squarepoint's LFST Position: Q1 2026 in Review

Squarepoint sold out of Lifestance Health (LFST) in Q1 2026, closing a stake of 433,231 shares — an estimated $3.05M sold.

Squarepoint first reported a position in LFST in Q2 2021 and held it in 14 quarters. The position peaked at $7.03M in Q2 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

Squarepoint reported no remaining Lifestance Health position as of Q1 2026 after selling out during the quarter.
Squarepoint sold 433,231 Lifestance Health shares in Q1 2026, an estimated $3.05M.
Squarepoint first reported a position in Lifestance Health in Q2 2021 and held it in 14 quarters.
Squarepoint's Lifestance Health position peaked at $7.03M in Q2 2025.
228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.